TrialBreast cancer research : BCR2024

Clinical characterization, prognostic, and predictive values of HER2-low in patients with early breast cancer in the PALLAS trial (ABCSG-42/AFT-05/BIG-14-13/PrE0109).

Guilherme Nader-Marta et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.